Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioDuro-Sundia Appoints Alan Findlater as CCO | Contract Pharma
Breaking News, Promotions & Moves

BioDuro-Sundia Appoints Alan Findlater as CCO

Findlater boasts 25+ years of experience in senior commercial leadership within the life sciences and pharmaceutical services sectors.

BioDuro-Sundia, a global contract research, development, and manufacturing organization (CRDMO) that launched a new compound management center earlier this year, has appointed Alan Findlater as Chief Commercial Officer.
 
Findlater has more than 25 years of experience in senior commercial leadership within the life sciences and pharmaceutical services sectors. He has a strong history of guiding high-performing teams of up to 150 members, overseeing intricate product and service portfolios, establishing valuable alliances with industry giants like Amgen, Pfizer, and Roche, and successfully implementing strategic growth initiatives worldwide.
 
“We are thrilled to welcome Alan Findlater to the BioDuro-Sundia executive team,” said Dr. Armin Spura, CEO of BioDuro-Sundia. “Alan’s vast experience and successful track record in the life sciences industry will be invaluable as we continue to enhance our commercial strategy, drive commercial success, and deliver innovative client-centric solutions that strengthen our market leadership.”
 
Findlater holds a bachelor’s in chemistry from the University of Strathclyde and an MBA from Warwick Business School, both in the U.K.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters